These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 2428949)

  • 1. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA15-3 serum levels in breast cancer and other malignancies--correlation with clinical course.
    Barak V; Carlin D; Sulkes A; Treves A; Biran S
    Isr J Med Sci; 1988; 24(9-10):623-7. PubMed ID: 3204010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
    Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
    Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
    Daly L; Ferguson J; Cram GP; Hars V; George SL; McCarty KS; Bast RC
    J Clin Oncol; 1992 Jul; 10(7):1057-65. PubMed ID: 1607912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer.
    Hou MF; Chen YL; Tseng TF; Lin CM; Chen MS; Huang CJ; Huang YS; Hsieh JS; Huang TJ; Jong SB; Huang YF
    Kaohsiung J Med Sci; 1999 Sep; 15(9):520-8. PubMed ID: 10561976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum CA15-3 and CEA in breast cancer.
    Hou MF; Huang TJ; Hsieh JS; Huang YS; Huang CJ; Chan HM; Wang JY; Chen YL; Jong SB; Yang CC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Dec; 11(12):660-6. PubMed ID: 8551526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125--results in immune and clinical responses in breast cancer patients.
    Jiang XP; Yang DC; Elliott RL; Head JF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):495-505. PubMed ID: 11155821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCA in patients with breast cancer: correlation with CEA and CA15-3.
    Molina R; Filella X; Mengual P; Prats M; Zanon G; Daniels M; Ballesta AM
    Int J Biol Markers; 1990; 5(1):14-21. PubMed ID: 2230347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of tumor marker CA15-3 in breast cancer].
    Kikuchi K; Uematsu Y; Takada Y; Kurihara E; Suito T; Fujisaki M; Takahashi R; Tamura T
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3095-100. PubMed ID: 3479052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.
    Sacks NP; Stacker SA; Thompson CH; Collins JP; Russell IS; Sullivan JA; McKenzie IF
    Br J Cancer; 1987 Dec; 56(6):820-4. PubMed ID: 2449238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the IMMULITE BR-MA and CEA assays and comparison with immunoradiometric assays for CA15-3 and CEA in breast cancer.
    Murray A; Willsher P; Price MR; Dixon AR; Robertson JF
    Anticancer Res; 1997; 17(3C):1945-9. PubMed ID: 9216649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
    Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
    Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer.
    Safi F; Kohler I; Röttinger E; Suhr P; Beger HG
    Int J Biol Markers; 1989; 4(4):207-14. PubMed ID: 2628501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.